What Is Thymalin?
Also known as: Thymic peptide bioregulator, Thymus extract peptide
Thymalin is a polypeptide complex extracted from calf thymus, standardized by the Khavinson group in St Petersburg and used in Russian medicine since the 1980s as an immunomodulator. Its synthetic dipeptide cousin, thymogen, is derived from the same work.
Its research story is immune restoration in aging: short courses were reported to normalize T-cell subsets, and a 6–8 year study in elderly patients reported lower rates of infection, cardiovascular disease and overall mortality in the treated group.
What is Thymalin studied for?
- •Age-related immune decline (Russian long-term trials)
- •Post-chemotherapy and post-radiation immune recovery
- •Chronic infections and impaired cellular immunity
- •Adjunct in oncology support (Russian practice)
Side effects & safety
Rarely reported — injection-site reactions and occasional low-grade fever. As a biological extract, batch consistency matters more than for synthetic peptides.
Legal & approval status
Registered medicine in Russia; not approved in the US or EU. Sold internationally as a research peptide.
Typical dosing at a glance
Related peptides
Educational overview based on published research and commonly reported community protocols — not medical advice, and not an endorsement of any compound. Consult a licensed healthcare provider.